QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020) 期刊论文 MOLECULAR CANCER, 2021, 卷号: 20, 期号: 1, 页码: 1 作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang 收藏  |  浏览/下载：57/0  |  提交时间：2021/11/04 Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文 Molecular Cancer, 2021, 卷号: 20, 期号: 1 作者:  Zhang,Tao;  Qu,Rong;  Chan,Shingpan;  Lai,Mengzhen;  Tong,Linjiang 收藏  |  浏览/下载：41/0  |  提交时间：2021/11/04 Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文 MOLECULAR CANCER, 2020, 卷号: 19, 期号: 1, 页码: 15 作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang 收藏  |  浏览/下载：39/0  |  提交时间：2020/07/01 Non-small cell lung cancer (NSCLC)  EGFR T790M  Small-molecule inhibitor  Drug resistance  Ack1   Discovery of JND3229 as a New EGFR(C797S) Mutant Inhibitor with In Vivo Monodrug Efficacy 期刊论文 ACS MEDICINAL CHEMISTRY LETTERS, 2018, 卷号: 9, 期号: 11, 页码: 1123-1127 作者:  Lu, Xiaoyun;  Zhang, Tao;  Zhu, Su-Jie;  Xun, Qiuju;  Tong, Lingjiang 收藏  |  浏览/下载：107/0  |  提交时间：2019/01/08 EGFR(C797s)  Clinical resistance  Fourth-generation nhibitors  Monodrug efficacy   Discovery of JND3229 as a New EGFR(C797S) Mutant Inhibitor with In Vivo Monodrug Efficacy 期刊论文 2018, 卷号: 9, 期号: 11, 页码: 1123 作者:  Lu, Xiaoyun[1];  Zhang, Tao[2,6,7];  Zhu, Su-Jie[3,4];  Xun, Qiuju[5];  Tong, Lingjiang[2] 收藏  |  浏览/下载：24/0  |  提交时间：2019/12/23 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L858R/T790M) 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 卷号: 25, 期号: 19, 页码: 4277-4281 作者:  Chan, Shingpan;  Han, Kun;  Qu, Rong;  Tong, Linjiang;  Li, Yingjun 收藏  |  浏览/下载：47/0  |  提交时间：2019/01/08 EGFR  IGF1R  NSCLC  Dual inhibitor   2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L858R/T790M) 期刊论文 2015, 卷号: 25, 期号: [db:dc_citation_issue], 页码: 4277 作者:  Chan, Shingpan[1,2];  Han, Kun[3];  Qu, Rong[2,3];  Tong, Linjiang[3];  Li, Yingjun[1,2] 收藏  |  浏览/下载：23/0  |  提交时间：2019/12/03 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L858R/T790M) 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 卷号: 25, 期号: 19, 页码: 4277-4281 Chan, Shingpan; Han, Kun; Qu, Rong; Tong, Linjiang; Li, Yingjun; Zhang, Zhang; Cheng, Huimin; Lu, Xiaoyun; Patterson, Adam; Smaill, Jeff; Ren, Xiaomei; Ding, Jian; Xie, Hua; Ding, Ke 收藏  |  浏览/下载：246/0  |  提交时间：2016/12/16 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L858R/T790M) 期刊论文 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 卷号: 25, 期号: 19, 页码: 4277-4281 作者:  Smaill, Jeff;  Lu, Xiaoyun;  Cheng, Huimin;  Zhang, Zhang;  Li, Yingjun 收藏  |  浏览/下载：48/0  |  提交时间：2018/12/13